BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/20/2023 5:54:58 AM | Browse: 34 | Download: 42
Publication Name World Journal of Clinical Cases
Manuscript ID 80573
Country/Territory China
Category Respiratory System
Manuscript Type Case Report
Article Title Envafolimab combined with chemotherapy in the treatment of combined small cell lung cancer: A case report
Manuscript Source Unsolicited Manuscript
All Author List Mei-Hong Liu, Yan-Xia Li and Zhuo Liu
Funding Agency and Grant Number
Funding Agency Grant Number
the Foundation of Science and Technology Bureau of Dalian 2021JJ13SN70
Corresponding Author Zhuo Liu, PhD, Doctor, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Dalian Medical University, No. 222 Zhongshan Road, Dalian 116011, Liaoning Province, China. liuzhuo@firstosp-dmu.com
Key Words Combined small cell lung cancer; Envafolimab; Carboplatin; Etoposide; Prognosis; Case report
Core Tip Combined small cell lung cancer (C-SCLC) is a special subtype of small cell lung cancer, which is relatively rare, aggressive, prone to early metastasis, and has a poor prognosis. With the development and progress of immunotherapy, several clinical studies have shown that programmed death ligand-1 combined with chemotherapy can effectively prolong the progression-free survival and median overall survival of patients with extensive stage small cell lung cancer, but its efficacy in C-SCLC is not exact. In this paper, we report a patient with extensive stage C-SCLC who was treated with envafolimab combined with carboplatin and etoposide with preliminary anti-tumor activity, safety and tolerability.
Citation Liu MH, Li YX, Liu Z. Envafolimab combined with chemotherapy in the treatment of combined small cell lung cancer: A case report. World J Clin Cases 2023; In press
2022-10-24 08:23
Peer-Review Started
2022-10-04 04:04
To Make the First Decision
Return for Revision
2022-12-19 07:27
2023-01-08 10:24
Second Decision
2023-01-20 03:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-01-20 05:54
Articles in Press
2023-01-20 05:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Dong-Mei Wang
Reviewer Code 06406907, and 06418652
Editorial Director
Journal Chief Editor
Company Chief Editor Jin-Lei Wang
Language Editor
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 80573_Auto_Edited-DMW-JLW.docx
Answering Reviewers 80573-Answering reviewers.pdf
Audio Core Tip 80573-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 80573-Conflict-of-interest statement.pdf
Copyright License Agreement 80573-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 80573-Grant application form(s).pdf
Signed Consent for Treatment Form(s) or Document(s) 80573-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 80573-Language certificate.pdf
Peer-review Report 80573-Peer-review(s).pdf
Scientific Misconduct Check 80573-Bing-Wang DM-1.png
Scientific Misconduct Check 80573-CrossCheck.png
Scientific Editor Work List 80573-Scientific editor work list.pdf